title: Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia.
authors.affiliation: Productos Roche, Bogota, Colombia.
authors.forename: Ariza S A
authors.initials: AS
authors.lastname: Saenz